Pharma Blog Watch

Rx-to-OTC Switches (Eye on FDA)
In his blog, Mark Senak discusses Rx-to-OTC switches, citing recent failures, and writes that in the future companies will have to "devise communications means that are much more intensive than labels to ensure proper patient understanding."